Immutep Limited (PRRUF) Financials

PRRUF Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 98.3 million 32.3 million
June 30, 2025 103.2 million 8.8 million
Dec. 31, 2024 113.3 million 6.1 million
June 30, 2024 134.5 million 8.0 million

PRRUF Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -19.2 million ?
June 30, 2025 -11.0 million 382581
Dec. 31, 2024 -12.5 million ?
June 30, 2024 -5.0 million ?

PRRUF Net Income

No data available :(

PRRUF Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 66.2 million 1.3 million 634017
June 30, 2025 85.3 million 207091 342158
Dec. 31, 2024 99.0 million 242985 405263
June 30, 2024 121.4 million 907740 422465

PRRUF Shares Outstanding

No data available :(

PRRUF Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 61861 - 34.0 million -
June 30, 2025 11267 11.9 million 1.5 million -
Dec. 31, 2024 146591 15.7 million 2.6 million -
June 30, 2024 32947 14.1 million 2.7 million -

PRRUF Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 2.7 million 753475
June 30, 2025 623451 11.9 million
Dec. 31, 2024 2.0 million 15.7 million
June 30, 2024 1.2 million 14.1 million

PRRUF

Price: $0.05

52 week price:
0.04
0.33

Earnings Per Share: -0.03 USD

P/E Ratio: -8.33

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 73.7 million

Links: